A Self-Reported Adherence Measure to Screen for Elevated HIV Viral Load in Pregnant and Postpartum Women on Antiretroviral Therapy

AIDS and Behavior

Volumn 21, Issue 2, 2017, Pages 450-461

  Phillips, Tamsin ^a   Brittain, Kirsty ^a   Mellins, Claude A ^b   Zerbe, Allison ^c   Remien, Robert H ^b   Abrams, Elaine J ^c,d   Myer, Landon ^a   Wilson, Ira B ^e  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^c Brown University School of Public Health ^*  (United States)

^d NONE   (United States)

^e BROWN UNIVERSITY   (United States)

Author keywords

Adherence; Maternal antiretroviral therapy; Psychometric scale; Self report; South Africa; Viral load

Indexed keywords

AREA UNDER THE CURVE; ATTENTION; CRONBACH ALPHA COEFFICIENT; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; MAJOR CLINICAL STUDY; MONITORING; PREGNANCY; SELF REPORT; SOUTH AFRICA; SPEECH; VIRUS LOAD; ADOLESCENT; ADULT; BLOOD; CROSS-SECTIONAL STUDY; HEALTH CARE PLANNING; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MEDICATION COMPLIANCE; PREGNANCY COMPLICATION; PREGNANT WOMAN; PSYCHOMETRY; PUERPERIUM; VIROLOGY; YOUNG ADULT;

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADOLESCENT; ADULT; ANTI-HIV AGENTS; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH RESOURCES; HIV INFECTIONS; HUMANS; MEDICATION ADHERENCE; POSTPARTUM PERIOD; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREGNANT WOMEN; PSYCHOMETRICS; SELF REPORT; SOUTH AFRICA; VIRAL LOAD; YOUNG ADULT;

EID: 84976295635     PISSN: 10907165     EISSN: 15733254     Source Type: Journal    
DOI: 10.1007/s10461-016-1448-0     Document Type: Article

References (45)

1. Loutfy MR, Wu W, Letchumanan M, Bondy L, Antoniou T, Margolese S, et al. Systematic review of HIV transmission between heterosexual serodiscordant couples where the HIV-positive partner is fully suppressed on antiretroviral therapy. PLoS One. 2013;8(2):e55747.
2. World Health Organisation. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. Recommendations for a publich health approach. Geneva: World Health Organization; (2013). http://www.who.int/hiv/pub/guidelines/arv2013/download/en/. Accessed 2 Feb 2015.
3. Ahmed S, Kim MH, Abrams EJ. Risks and benefits of lifelong antiretroviral treatment for pregnant and breastfeeding women: a review of the evidence for the option B + approach. Curr Opin HIV AIDS. 2013;8(5):474–89.
4. Vrijens B, De Geest S, Hughes DA, Przemyslaw K, Demonceau J, Ruppar T, et al. A new taxonomy for describing and defining adherence to medications. Br J Clin Pharmacol. 2012;73(5):691–705.
5. Nachega JB, Uthman O, Anderson J, Peltzer K, Wampold S, Cotton MF, et al. Adherence to antiretroviral therapy during and after pregnancy in low-income, middle-income, and high-income countries: a systematic review and meta-analysis. AIDS. 2012;26(16):2039–52.
6. Clouse K, Pettifor A, Maskew M, Bassett J, Van Rie A, Gay C, et al. Initiating antiretroviral therapy when presenting with higher CD4 cell counts results in reduced loss to follow-up in a resource-limited setting. AIDS. 2013;27(4):645–50.
7. Psaros C, Remmert JE, Bangsberg DR, Safren SA, Smit JA. Adherence to HIV care after pregnancy among women in Sub-Saharan Africa: falling off the cliff of the treatment cascade. Curr HIV/AIDS Rep. 2015;12(1):1–5.
8. Duong M, Piroth L, Peytavin G, Forte F, Kohli E, Grappin M, et al. Value of patient self-report and plasma human immunodeficiency virus protease inhibitor level as markers of adherence to antiretroviral therapy: relationship to virologic response. Clin Infect Dis. 2001;33(3):386–92.
9. Simoni JM, Kurth AE, Pearson CR, Pantalone DW, Merrill JO, Frick PA. Self-report measures of antiretroviral therapy adherence: a review with recommendations for HIV research and clinical management. AIDS Behav. 2006;10(3):227–45.
10. Okonji JA, Zeh C, Weidle PJ, Williamson J, Akoth B, Masaba RO, et al. CD4, viral load response, and adherence among antiretroviral-naive breast-feeding women receiving triple antiretroviral prophylaxis for prevention of mother-to-child transmission of HIV in Kisumu, Kenya. J Acquir Immune Defic Syndr. 2012;61(2):249–57.
11. Nachega JB, Hislop M, Dowdy DW, Chaisson RE, Regensberg L, Maartens G. Adherence to nonnucleoside reverse transcriptase inhibitor-based HIV therapy and virologic outcomes. Ann Intern Med. 2007;146:564–73.
12. Calmy A, Ford N, Hirschel B, Reynolds SJ, Lynen L, Goemaere E, et al. HIV viral load monitoring in resource-limited regions: optional or necessary? Clin Infect Dis. 2007;44(1):128–34.
13. Bonner K, Mezochow A, Roberts T, Ford N, Cohn J. Viral load monitoring as a tool to reinforce adherence: a systematic review. J Acquir Immune Defic Syndr. 2013;64(1):74–8.
14. Garfield S, Clifford S, Eliasson L, Barber N, Willson A. Suitability of measures of self-reported medication adherence for routine clinical use: a systematic review. BMC Med Res Methodol. 2011;11(1):149–57.
15. Williams AB, Amico KR, Bova C, Womack J. A proposal for quality standards for measuring medication adherence in research. AIDS Behav. 2013;17(1):284–97.
16. Berg K, Arnsten J. Practical and conceptual challenges in measuring antiretroviral adherence. J Acquir Immune Defic Syndr. 2006;43(S1):S79–87.
17. Thompson MA, Mugavero MJ, Rivet Amico K, Cargill VA, Chang LW, Gross R, et al. Guidelines for improving entry into and retention in care and antiretroviral adherence for persons with HIV: evidence-based recommendations from an international association of physicians in AIDS care panel. Ann Intern Med. 2012;156(11):817–33.
18. Bärnighausen T, Chaiyachati K, Chimbindi N, Peoples A, Haberer J, Newell ML. Interventions to increase antiretroviral adherence in sub-Saharan Africa: a systematic review of evaluation studies. Lancet Infect Dis. 2011;11(12):942–51.
19. Sangeda RZ, Mosha F, Prosperi M, Aboud S, Vercauteren J, Camacho RJ, et al. Pharmacy refill adherence outperforms self-reported methods in predicting HIV therapy outcome in resource-limited settings. BMC Public Health. 2014;14(1):1035.
20. Genberg BL, Wilson IB, Bangsberg DR, Arnsten J, Goggin K, Remien RH, et al. Patterns of antiretroviral therapy adherence and impact on HIV RNA among patients in North America. AIDS. 2012;26(11):1415–23.
21. Nieuwkerk PT, Oort FJ. Self-reported adherence to antiretroviral therapy for HIV-1 infection and virologic treatment response: a meta-analysis. J Acquir Immune Defic Syndr. 2005;38(4):445–8.
22. Glass T, Cavassini M. Asking about adherence—from flipping the coin to strong evidence. Swiss Med Wkly. 2014;144:w14016.
23. Wilson IB, Carter A, Berg K. Improving the self-report of HIV antiretroviral medication adherence: is the glass half full or half empty? Curr HIV/AIDS Rep. 2009;6(4):177–86.
24. Simoni JM, Huh D, Wang Y, Wilson IB, Reynolds NR, Remien RH, et al. The validity of self-reported medication adherence as an outcome in clinical trials of adherence-promotion interventions: findings from the MACH14 study. AIDS Behav. 2014;18(12):2285–90.
25. Steel G, Nwokike J, Joshi MP. Development of a multi-method tool to measure ART adherence in resource-constrained settings: the South Africa experience. Arlington, VA: Management Sciences for Health; (2007). http://apps.who.int/medicinedocs/en/d/Js21890en. Accessed 9 June 2015.
26. Wilson IB, Fowler FJ, Cosenza CA, Michaud J, Bentkover J, Rana A, et al. Cognitive and field testing of a new set of medication adherence self-report items for HIV care. AIDS Behav. 2014;18:2349–58.
27. Wilson IB, Lee Y, Michaud J, Fowler FJ, Rogers WH. Validation of a new three-item self-report measure for medication adherence. AIDS Behav. 2016. doi:10.1007/s10461-016-1406-x.
28. Fowler FJ, Lloyd SJ, Cosenza CA, Wilson IB. Coding cognitive interviews: an approach to enhancing the value of cognitive testing for survey question evaluation. Field Methods. 2014;28:1–18.
29. Thirumurthy H, Siripong N, Vreeman RC, Pop-Eleches C, Habyarimana J, Sidle J, et al. Differences between self-reported and electronically monitored adherence among patients receiving antiretroviral therapy in a resource-limited setting. AIDS. 2012;26(18):2399–403.
30. Hodgson I, Plummer ML, Konopka SN, Colvin CJ, Jonas E, Albertini J, et al. A systematic review of individual and contextual factors affecting art initiation, adherence, and retention for HIV-infected pregnant and postpartum women. PLoS One. 2014;9(11):e111421.
31. Western Cape Government. PMTCT clinical guidelines update. Cape Town, South Africa: (2013). https://www.westerncape.gov.za/assets/departments/health/wcp_2013_pmtct_clinical_guidelines_update_final_replacement_2.pdf. Accessed 2 Feb 2015.
32. World Health Organisation. Process of translation and adaptation of instruments. Geneva, Switzerland: (2013). http://www.who.int/substance_abuse/research_tools/translation/en/. Accessed 10 Jan 2013.
33. Cox J, Holden J, Sagovsky R. Detection of postnatal depression: development of the 10-item Edinburgh postnatal depression scale. Br J Psychiatry. 1987;150:782–6.
34. Bush K, Kivlahan D, McDonell M, Fihn S, Bradley K. The AUDIT alcohol consumption questions (AUDIT-C): an effective brief screening test for problem drinking. Ambulatory care quality improvement project (ACQUIP). Alcohol use disorders identification test. Arch Intern Med. 1998;158(16):1789–95.
35. Read PJ, Mandalia S, Khan P, Harrisson U, Naftalin C, Gilleece Y, et al. When should HAART be initiated in pregnancy to achieve an undetectable HIV viral load by delivery? AIDS. 2012;26:1095–103.
36. Chaiyachati K, Hirschhorn LR, Tanser F, Newell M-L, Bärnighausen T. Validating five questions of antiretroviral nonadherence in a public-sector treatment program in rural South Africa. AIDS Patient Care STDS. 2011;25(3):163–70.
37. Kagee A, Nel A. Assessing the association between self-report items for HIV pill adherence and biological measures. AIDS Care. 2012;24(11):1448–52.
38. Berg K, Wilson I, Li X, Arnsten J. Comparison among antiretroviral adherence questions. AIDS Behav. 2012;16(2):461–8.
39. Robbins RN, Spector AY, Mellins CA, Remien RH. Optimizing ART adherence: update for HIV treatment and prevention. Curr HIV/AIDS Rep. 2014;11(4):423–33.
40. Kreitchmann R, Harris DR, Kakehasi F, Haberer JE, Cahn P, Losso M, et al. Antiretroviral adherence during pregnancy and postpartum in Latin America. AIDS Patient Care STDS. 2012;26(8):486–95.
41. Deschamps AE, De Geest S, Vandamme A-M, Bobbaers H, Peetermans WE, Van Wijngaerden E. Diagnostic value of different adherence measures using electronic monitoring and virologic failure as reference standards. AIDS Patient Care STDS. 2008;22(9):735–43.
42. Walsh JC, Mandalia S, Gazzard BG. Responses to a 1 month self-report on adherence to antiretroviral therapy are consistent with electronic data and virological treatment outcome. AIDS. 2002;16(2):269–77.
43. Wu P, Johnson BA, Nachega JB, Wu B, Ordonez CE, Hare AQ, et al. The combination of pill count and self-reported adherence is a strong predictor of first-line ART failure for adults in South Africa. Curr HIV Res. 2014;12(5):366–75.
44. Abah IO, Ojeh VB, Musa J, Ugoagwu P, Agaba PA, Agbaji O, et al. Clinical utility of pharmacy-based adherence measurement in predicting virologic outcomes in an adult HIV-infected cohort in Jos, North Central Nigeria. J Int Assoc Provid AIDS Care. 2014. doi:10.1177/2325957414539197.
45. Goldman JD, Cantrell RA, Mulenga LB, Tambatamba BC, Reid SE, Levy JW, et al. Simple adherence assessments to predict virologic failure among HIV-infected adults with discordant immunologic and clinical responses to antiretroviral therapy. AIDS Res Hum Retrovir. 2008;24(8):1031–5.